Table 1. Patient Characteristics.
| Variable | Low (n = 19) | Intermediate (n = 18) | High (n = 18) | p value |
|---|---|---|---|---|
| Age (years) | 69.2 ± 8.7 | 67.4 ± 10.2 | 64.1 ± 15.3 | 0.41 |
| Men | 10 (53%) | 15 (83%) | 17 (94%) | 0.007 |
| Body mass index (kg/m2) | 22.6 ± 3.5 | 24.1 ± 3.8 | 25.6 ± 3.7 | 0.049 |
| Hypertension | 15 (79%) | 12 (67%) | 16 (89%) | 0.28 |
| Diabetes mellitus | 6 (32%) | 7 (39%) | 4 (22%) | 0.57 |
| Dyslipidemia | 11 (58%) | 15 (83%) | 15 (83%) | 0.12 |
| Current smoker | 4 (21%) | 8 (44%) | 6 (33%) | 0.33 |
| Prior myocardial infarction | 2 (11%) | 2 (11%) | 2 (11%) | > 0.99 |
| Clinical presentation | ||||
| STEMI | 10 (53%) | 10 (56%) | 9 (50%) | |
| NSTEMI | 5 (26%) | 7 (39%) | 7 (39%) | 0.72 |
| Unstable angina | 4 (21%) | 1 (6%) | 2 (11%) | |
| eGFR (ml/min/1.73 m2) | 78.9 ± 18.1 | 72.2 ± 17.1 | 58.6 ± 18.5 | 0.004 |
| Serum uric acid (mg/dl) | 4.1 ± 0.9 | 5.8 ± 0.4 | 7.4 ± 0.6 | < 0.001 |
| Medical treatment on admission | ||||
| ACE-I or ARB | 7 (37%) | 6 (33%) | 12 (67%) | 0.09 |
| β blocker | 2 (11%) | 2 (11%) | 6 (33%) | 0.13 |
| Calcium channel blocker | 6 (32%) | 5 (28%) | 5 (28%) | 0.96 |
| Diuretic | 1 (5%) | 2 (11%) | 2 (11%) | 0.78 |
| Statin | 5 (26%) | 4 (22%) | 4 (22%) | 0.95 |
| Antihyperuricemic agent | 3 (16%) | 1 (6%) | 5 (28%) | 0.20 |
Patients were divided into 3 groups according to tertiles of SUA level. ACE-I = angiotensin converting enzyme inhibitor; ARB = angiotensin II receptor blocker; eGFR = estimate glomerular filtration rate; NSTEMI = non-ST elevation myocardial infarction; STEMI = ST elevation myocardial infarction.